In patients with high-grade atrioventricular block (AVB), a standard dual-chamber pacemaker can restore A-V synchrony and ensure an adequate ventricular pacing rate. In this setting, however, the ...

Background Studies of cardiac resynchronization therapy in addition to an implantable cardioverter defibrillator in patients with mild to moderate congestive heart failure had not been shown to reduce ...

The loss of coordinated myocardial contraction that occurs as a result of conduction delay is referred to as dyssynchrony and may be evaluated in a number of ways, usually involving echocardiography.

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

A meta-analysis by investigators from FDA of three major trials of cardiac resynchronization therapy (CRT) demonstrated that women have a reduced rate of heart failure (HF) and death with CRT at a ...

Heart failure remains a huge health care burden, with one in nine death certificates in the United States listing it as the cause of death. 1 Medical therapy has improved the prognosis for patients ...

Reduced cardiac efficiency caused by suboptimal synchronization of the heart's normal contraction might contribute to the development of or exacerbate heart failure. Conceptually and in practice ...

Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronization, according to a Late-Breaking Science presentation at EHRA 2026, the annual congress of ...

A 69-year-old man with a history of severe nonischemic cardiomyopathy managed with a cardiac resynchronization-defibrillator presented to the outpatient clinic with uncomfortable pulsation over the ...

Left bundle branch area pacing is an effective and practical strategy for cardiac resynchronization, according to a late-breaking science presentation at EHRA 2026, the annual congress of the European ...

To the Editor: In the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT), Moss and colleagues (Oct. 1 issue) 1 enrolled minimally symptomatic ...